Town of Cochrane Posts Executive Assistant Job Opening, Application Deadline August 1
The Town of Cochrane is seeking applicants for the position of Executive Assistant, with the application deadline set for Friday, August 1, 2025, at 3:00 p.m. The job is a full-time, non-union role within the Administration Department, based in Cochrane, Ontario, reporting directly to the Chief Administrative Officer.
According to the official job posting, the Executive Assistant is responsible for providing executive, administrative, and confidential support to the Chief Administrative Officer. The position involves managing sensitive information related to labour negotiations, legal matters, and senior personnel files, as well as supporting public communications and corporate coordination.
The salary range for the position is listed as $69,799 to $78,555 per year, with a comprehensive benefits package and participation in OMERS, a defined benefit pension plan. The role is 35 hours per week, from Monday to Friday, 8:30 a.m. to 4:30 p.m.
Minimum qualifications include strong proficiency in Microsoft Office applications, experience with content management systems, and a demonstrated ability to handle confidential and privileged information. Applicants must have excellent written and verbal communication skills, strong organizational abilities, and the ability to manage multiple deadlines. Familiarity with municipal government operations and labour environments is considered an asset. Candidates are expected to have post-secondary education in fields such as business administration, public administration, or legal studies, or a combination of equivalent education and experience. A minimum of two years’ experience in an executive assistant, legal, or human resources support role is required, preferably in a municipal or public sector setting. Bilingualism in English and French is considered an asset.
Further details on requirements and responsibilities are available in the Executive Assistant Job Description provided by the Town of Cochrane.